ASX Share rice
Thu 13 May 2021 - 01:18:pm (Sydney)

OSP Share Price

OSPREY MEDICAL INCOSPHealth Care Equipment & Services

OSP Company Information


Osprey Medical, Inc




Medical Devices


5600 Rowland Road Minnetonka MN United States 55343


952 955 8230

Pres, CEO & Exec. Director:

Mr. Michael McCormick


Dr. J. Edward Shapland

VP of Fin. & CFO:

Ms. Nancy Ness

VP of Operations & IT:

Mr. Vic Fabano

VP of Regulatory Affairs, Compliance & Quality:

Ms. Melanie Hess

VP of Marketing, Education & Reimbursement:

Mr. Doug Schoenberg

Company Sec.:

Mr. Brendan T. Case C.P.A., BEc, Grad Dip., MComLaw, CPA, Dip FP

Company Overview:

Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally. It offers AVERT, AVERT Plus, DyeVert NG, DyeVert Plus System, and DyeVert Plus EZ Systems, which are used to protect patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.

OSP Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


OSP CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Change To Inventory:


Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


OSP Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Income Tax Expense:


Total Revenue:


Cost Of Revenue:


OSP Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Retained Earnings:


Other Assets:




Total Current Liabilities:


Short-Term Debt:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:




Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


OSP Share Price History

OSP News

13 Jan, 2021
For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk...
08 Dec, 2020
Peter Bender is the CEO of Huon Aquaculture Group Limited ( ASX:HUO ), and in this article, we analyze the executive's...
02 Nov, 2020
In this article we are going to estimate the intrinsic value of Huon Aquaculture Group Limited (ASX:HUO) by taking the...
12 Oct, 2020
We feel now is a pretty good time to analyse Osprey Medical, Inc.'s (ASX:OSP) business as it appears the company may...
29 Sep, 2020
Osprey Medical, Inc. (ASX:OSP) (Osprey or the Company) is pleased to announce that the Company is a winner of the prestigious Supplier Horizon Award from Premier Inc., one of the leading Group Purchasing Organisations (GPOs) in the US with over 4,100 member hospitals in its network.
13 Aug, 2020
Osprey Medical, Inc. (ASX:OSP) (Osprey or the Company) is pleased to announce that the Company has received CE Marking for the DyeVert Power XT 2nd generation device.
30 Jul, 2020
GE Healthcare and Osprey Medical Inc. (ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. Osprey’s DyeVert™ contrast minimization devices, complemented by GE Healthcare's range of iodinated x-ray contrast media, offer healthcare professionals a technology platform to address the rising problem of Acute Kidney Injury (AKI) following interventional coronary angiograms in patients with Chronic Kidney Disease (CKD).